Guggenheim raised the firm’s price target on Itron (ITRI) to $155 from $133 and keeps a Buy rating on the shares. Despite a continuing positive stance, the firm no longer sees upside sufficient to merit keeping Itron as a Best Idea, and is removing the Best Idea designation for the company, the analyst tells investors in a research note. Guggenheim expects more meaningful improvement in the Outcomes segment in 2026 and 2027.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
- Itron has shipped more than 2M Cyble 5 communication module
- Itron signs contract with HEDNO to lay foundation for grid edge intelligence
- Itron price target raised to $145 from $139 at TD Cowen
- Itron exec Patrick sells 9,036 common shares
- Itron’s Strategic Advantage in Grid Modernization and Market Consolidation